203 related articles for article (PubMed ID: 14627174)
21. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing.
Ställberg B; Olsson P; Jörgensen LA; Lindarck N; Ekström T
Int J Clin Pract; 2003 Oct; 57(8):656-61. PubMed ID: 14627173
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
Price D; Wirén A; Kuna P
Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
[TBL] [Abstract][Full Text] [Related]
24. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
[TBL] [Abstract][Full Text] [Related]
25. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
Buhl R; Vogelmeier C
Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
[TBL] [Abstract][Full Text] [Related]
26. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
Price D; Haughney J; Lloyd A; Hutchinson J; Plumb J
Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
[TBL] [Abstract][Full Text] [Related]
27. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.
Papi A; Paggiaro PL; Nicolini G; Vignola AM; Fabbri LM;
Eur Respir J; 2007 Apr; 29(4):682-9. PubMed ID: 17107988
[TBL] [Abstract][Full Text] [Related]
28. A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management.
Louis R; Joos G; Michils A; Vandenhoven G
Int J Clin Pract; 2009 Oct; 63(10):1479-88. PubMed ID: 19769705
[TBL] [Abstract][Full Text] [Related]
29. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
Tarsin WY; Pearson SB; Assi KH; Chrystyn H
Int J Pharm; 2006 Jun; 316(1-2):131-7. PubMed ID: 16584855
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma.
Ankerst J; Persson G; Weibull E
Pulm Pharmacol Ther; 2003; 16(3):147-51. PubMed ID: 12749830
[TBL] [Abstract][Full Text] [Related]
31. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
Berger WE; Noonan MJ
J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
[TBL] [Abstract][Full Text] [Related]
32. Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone.
Zetterström O; Buhl R; Mellem H; Perpiñá M; Hedman J; O'Neill S; Ekström T
Eur Respir J; 2001 Aug; 18(2):262-8. PubMed ID: 11529282
[TBL] [Abstract][Full Text] [Related]
33. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
[TBL] [Abstract][Full Text] [Related]
34. The whole story: treatment outcomes with Symbicort.
Zetterström ; Buhl R; Mellem H; Andersson F
Respir Med; 2002 Feb; 96 Suppl A():S29-35. PubMed ID: 11858563
[TBL] [Abstract][Full Text] [Related]
35. The functionality of a budesonide/formoterol pressurized metered-dose inhaler with an integrated actuation counter.
Shah S; White M; Uryniak T; O'Brien CD
Allergy Asthma Proc; 2010; 31(1):40-8. PubMed ID: 20167144
[TBL] [Abstract][Full Text] [Related]
36. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M
J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of high-dose budesonide/formoterol (Symbicort) compared with budesonide administered either concomitantly with formoterol or alone in patients with persistent symptomatic asthma.
Jenkins C; Kolarikova R; Kuna P; Caillaud D; Sanchis J; Popp W; Pettersson E
Respirology; 2006 May; 11(3):276-86. PubMed ID: 16635085
[TBL] [Abstract][Full Text] [Related]
38. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.
Balanag VM; Yunus F; Yang PC; Jorup C
Pulm Pharmacol Ther; 2006; 19(2):139-47. PubMed ID: 16009588
[TBL] [Abstract][Full Text] [Related]
40. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]